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Abstract
High-resolution magnetic resonance imaging (MRI) may improve the preoperative
diagnosis of focal cortical dysplasia (FCD) in epilepsy. Quantitative 9.4T MRI was
carried out (T1, T2, T2* and magnetization transfer ratio) on 13 cortical resections,
representing pathologically confirmed FCD (five cases) and normal cortex. Quantitative
immunohistochemistry for myelination (myelin basic protein/SMI94), neuronal popula-
tions [microtubule-associated protein 2 (MAP2), neurofilament (SMI31, SMI32),
synaptophysin, NeuN, calbindin], reactive glia (GFAP), microglia (CD68) and blood–brain
barrier permeability (albumin) was carried out in 43 regions of interest (ROI) from normal
and abnormal white matter and cortex. MRI was spatially aligned and quantitative analysis
carried out on corresponding ROI. Line profile analysis (LPA) of intensity gradients
through the cortex was carried out on MRI and immunostained sections. An inverse
correlation was noted between myelin/SMI94 and T1, T2 (P < 0.005) and T2* (P < 0.05;
Spearman’s correlation) and a positive correlation between neuronal MAP2 and T1
(P < 0.005) and T2* (P < 0.05) over all ROI. Similar pathology–MRI correlations were
observed for histologically unremarkable white matter ROI only. LPA showed altered
gradient contours in regions of FCD, reflecting abnormal cortical lamination and myelo-
architecture, including a preoperatively undetected FCD case. This study demonstrates the
ability of quantitative 9.4T MRI to detect subtle differences in neuronal numbers and
myelination in histologically normal appearing white matter and LPA in the evaluation of
cortical dyslamination. These methods may be translatable to the in vivo detection of mild
cortical malformations.
INTRODUCTION
A proportion of localized structural brain abnormalities and mal-
formations causing epilepsy remain “occult” preoperatively, with
current magnetic resonance imaging (MRI) technologies. These
include cases of pathologically confirmed focal cortical dysplasia
(FCD) type II (33) as well as milder malformations of cortical
development [mild malformations of cortical development
(MCD)] (3, 22). Advanced MRI techniques have the potential to
improve the identification and characterization of these lesions.
This improvement, however, is dependent on a thorough under-
standing of the cellular basis of these techniques, best achieved
by correlating the lesion’s magnetic resonance (MR) and its
pathology directly with each other (22). High-resolution MRI
(7T and 9.4T) of tissue samples followed by histology has been
utilized to study post-mortem (PM) cortical alterations in multiple
sclerosis (17, 27),Alzheimer’s disease (14, 29), schizophrenia (18)
as well variations in normal brain myelo-architecture and cyto-
architecture (10, 16, 34) including epilepsy surgical samples (11,
12). Many of these previous studies have used traditional Nissl and
myelin stains for pathological qualitative or quantitative analysis
(10, 12, 16, 34). With the application of immunohistochemistry to
specific cellular and structural components of cortical laminae and
white matter, there is further potential to dissect out the cellular
basis of MRI signal alterations in “cryptogenic” focal epilepsies.
Furthermore, varying reactive pathological changes are frequently
noted in surgical epilepsy specimens, including gliosis, inflamma-
tion and blood–brain barrier breakdown (1, 32), which could
potentially also influence MRI signals and need to be accounted
for.
Previous quantitative neuroimaging and pathology correlative
studies have generally relied on the analysis of small regions of
interest (ROIs) in tissue samples (9, 21), which is dependent on
accuracy of co-registration between sample and MRI (8) and may
not be representative of the entire pathology, particularly in more
ill-defined lesions as mild MCD. Whole slide quantitative analysis
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methods (WSA) maximize the tissue areas analyzed, and we have
recently shown this to be a more reliable quantitative application in
the study of mild MCD (19). Confirmed pathology–imaging cor-
relations based on ex vivo high-field MRI of tissue specimens have
the potential to be translated to the in vivo characteristics of these
lesions and ultimately to improve detection, and potentially delin-
eate the boundaries of these lesions, prior to surgery (22).
We present a series of cases where high-field 9.4T MRI and
quantitative analysis has been carried out on surgical samples from
patients with focal epilepsy including histologically normal and
dysplasia cases. We employed quantitative immunohistochemistry
for a broad range of neuronal, glial, microglial, myelin and vascu-
lar markers, including the application ofWSA analysis, in order to
further explore the relationship between pathological features and
MR signal change in epilepsy cortical resections. Our aims were to
identify quantitative MRI (qMRI) measures that could be of pre-
dictive value in the preoperative evaluation of focal epilepsy, in
particular FCD types and mild MCD.
METHODS
Case selection
The specimens were selected prospectively from adult patients
undergoing surgical treatment for epilepsy at the National Hospital
for Neurology and Neurosurgery, Queen Square, during the period
2011–2013. Twelve cases were studied after obtaining preopera-
tive consent for use of surgical tissue, and the study has approval
through the ethics committee of the UCL, Epilepsy Society Brain
and Tissue Bank. To correlate these samples with a reference,
normal control tissue, a further sample from a PM of a patient
without cortical neuropathology or history of epilepsy was
included. The clinical details including epilepsy history and preop-
erative MRI diagnosis are presented in Table 1. The preoperative
suspected diagnosis included FCD subtypes (five cases),
hippocampal sclerosis (1) and dysembryoplastic neuroepithelial
tumor (1). The resections were from the frontal lobe (eight cases),
temporal lobe (three cases), parietal lobe (one case) and occipital
lobe (one case); the control PM tissue was from the temporal lobe.
Sample preparation
In each of the 13 cases, a section of cortex and underlying white
matter of 5-mm thickness was sliced using a cradle as previously
described (8) and fixed for a minimum period of 5 days in formalin.
Either one or two such samples from each case were selected for
9.4T imaging, aiming to include macroscopically pathological and
normal cortex as well as white matter in all cases. The sample was
fixed rigidly in a tissue-tek® (Sakura,Tatcham, UK) cassette, which
was held tightly within a plastic tube to minimize movement
artifacts and filled with fomblin® perfluoro polyether (LC 08,
Solvay Solexis, Milan, Italy) to avoid susceptibility artifacts. In a
previous pilot study carried out on PM tissues, there were no
adverse effects of the fomblin medium on tissue processing and
immunostaining protocols.
MRI protocol
The samples were scanned on a 9.4T MR scanner (Agilent Tech-
nologies, Santa Clara, CA, USA) using a volume coil with a
diameter of 33 mm (Rapid Biomedical GmbH, Rimpar, Germany).
The applied overnight MRI protocol consisted of T2-weighted
images and T1, T2, T2* and magnetization transfer ratio (MTR)
maps. Multi-slice spin echo sequences were used for the acquisi-
tion of these data except for the T2* and MTR maps where multi-
slice gradient echo sequences were applied. After manual global
shimming and acquiring fast localization images, 12 slices were
acquired using a field of view of 35 × 35 mm2, an in-plane spatial
resolution of 136 × 136 μm2 and a slice thickness of 500 μm.
Depending on the contrast, the echo time (TE) and the repetition
time (TR) were:
(i) T2-weighted images: TE = 55 ms, TR = 4500 ms and the
acquisition time (TA) was 96 minutes.
(ii) T1 maps: TE = 10 ms, TR = 0.3/0.5/0.8/1.3/2/4 s and
TA = 145 minutes.
(iii) T2 maps: TR = 2 s, TE = 12.6/20/35/60 ms and TA = 102
minutes.
(iv) T2* maps: TR = 290 ms, TE = 5.2/7/9/11/13/20 ms, flip
angle (FA) = 40° and TA = 75 minutes.
(v) MTR maps: TR = 260 ms, TE = 5 ms and FA = 40°. Two fre-
quency offsets of the saturation RF pulse were used: 6 kHz (MT
weighted) and 100 kHz (control). TA = 65 minutes.
The total scanning time for the entire protocol was approxi-
mately 8 h. T1, T2, T2* and MTR maps were obtained by process-
ing the data using both an in-house developed script running under
Matlab (Mathworks, Massachusetts, USA) and ImageJ (National
Institutes of Health, Bethesda, MD, USA; http://imagej.nih.gov/ij/
index.html).
Immunohistochemistry and quantitation
on ROIs
The tissue samples were then routinely processed, sections cut at
7 μm and an immunohistochemistry panel applied as detailed in
Table 2. All sections were assessed qualitatively for the pathology
present on the scanned section as detailed in Table 3. Between
three and four ROIs were outlined on each of the pathology sec-
tions to include normal, as well as pathological, white matter and
cortex as detailed in Table 3. The histological sections were manu-
ally spatially aligned with the MRI-scanned images, matching
anatomical landmarks in the section, corresponding ROIs identi-
fied and qMRI values for T1, T2, T2* and MTR calculated for each
area. Quantitative evaluation of immunohistochemistry staining
was carried out on neurofilament (SMI32), myelin basic protein
(MBP/SMI94), microtubule-associated protein 2 (MAP2),
synaptophysin, microglial marker CD68, albumin (for loss of
integrity of blood–brain barrier) and GFAP (for astrogliosis)
stained sections with Image Pro Plus software (Media Cybernetics,
Buckinghamshire, UK). Using RGB thresholding, the
immunostaining reaction was detected in all fields within the ROI,
captured sequentially at ×40 objective (Nikon Eclipse microscope
and camera). An average of 71 high power fields (SD 25) were
captured for white matter ROI and 69 fields (SD 27) for gray
matter. A mean labeling index (LI) was then calculated for each
ROI. Repeat measurements were carried out onMAP2, SMI94 and
GFAP section (between 12 and 30 ROI), which showed reproduc-
ibility; intraclass correlation coefficients of 0.81, 0.67 and 0.88,
respectively. NeuN was not included in quantitative analysis due to
the noted variability in the intensity of staining with longer fixation
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times (20); CD34- and nestin-labeled sections were also not evalu-
ated quantitatively due to the overall paucity of positively labeled
cells.
Whole slide scanning
Based on initial findings from the ROI analysis, SMI94/MBP- and
MAP2-stained sections from each case were selected for whole
slide scanning analysis. Slides were scanned with a Leica
SCN400F digital slide scanner (Leica Microsystems, Wetzlar,
Germany); images were processed into a Pyramid TIFF file, stored
on a fileserver and viewed and managed on the SlidePath Digital
Image Hub (Leica).Analysis was carried out with Definiens Tissue
Studio 3.6 (Definiens AG, Munich, Germany) as follows. The
entire area of white matter was outlined on each image using a
stylus pen on a touch-sensitive computer screen, drawn at a set
distance of 0.5 mm from the cortical margin, to exclude layer VI
neurons. The mean area was 29.4 mm2 (range 7–63 mm2) for
MAP2 and 40 mm2 (range 13.5–84 mm2) for SMI94/MBP. The
intensity threshold for detection of immunostaining was preset in
a selected area then the entire image was processed and the LI
calculated for the entire outlined white matter.
Line profile analysis (LPA) in the assessment
of lamination
In seven cases (4, 6, 8–11, 13), LPA was carried out. Regions of
normal laminated cortex were selected and/or a region (cases 4, 10
and 13) with dysplasia and dyslamination. On all immunostained
sections, images of the full cortical thickness were captured at ×4.7
magnification, converted to gray scale and the intensity scale of
pixels along a vectors perpendicular to the pial surface through all
cortical layers were analyzed with Image Pro Plus software. In
addition, the approximate distance of each cortical layer from the
pial surface was measured on NeuN-stained sections of normal
laminar cortex. Similar LPA of matched cortical regions was
carried out on all MRI sequences.
Statistical analysis was carried out with SPSS (version 21
for Windows, IBM Corporation, Armonk, NY, USA) using
nonparametric correlation tests for the comparison of MRI and
pathology measures (Spearman’s correlation and Mann–Whitney
test).
RESULTS
The pathological diagnosis on the sections selected for 9.4T was
FCD IIa in one case, FCD IIb in two cases, FCD IIId in one case
and “pathology negative” (no focal lesional pathology) in nine
cases; in three cases intracranial electrode (ICE) injury sites were
also present (Table 3).
Quantitative pathology and MRI measurements
There were 43 ROI analyzed in all; 24 in white matter and 19 in
cortex with 31 in histologically normal appearing areas and 12 in
pathological areas. There were significant differences in quantita-
tive pathology measures between normal cortical ROI and normal
white matter ROI for GFAP (P < 0.05), SMI94/MBP (P < 0.001),
MAP2 (P < 0.0001), CD68 (P < 0.05) and synaptophysin
(P < 0.001) but not for neurofilament or albumin (Figure 1A).
When these measures were compared between normal white
matter ROI and FCD white matter ROI, a significant reduction was
observed for SMI94/MBP (P < 0.05) (Figure 1B); although the
number of FCD cases is small, this finding is in keeping with
previous observations of reduced myelin in dysplastic region (28).
There were no differences for normal cortical ROI and FCD cor-
tical ROI. For qMRI measures, significant differences were
observed for T1 (P < 0.01), T2 (P < 0.05), T2* (P < 0.0001) and
MTR (P < 0.0001) between cortex and white matter ROI
(Figure 1C), between normal white matter and FCD white matter
Table 2. Immunohistochemistry panel.
Abbreviations: BC = balloon cells; DN = dysmorphic neurons; FCD = focal cortical dysplasia; GFAP = glial fibrillary acidic protein; LEAT = long-term
epilepsy associated tumor; LPA = line profile analysis; MAP2 = microtubule-associated protein 2; ROI = region of interest study where small areas
of interest were analyzed; WSA = whole slide analysis study.
Antibody Structure/cells labeled Source; (dilution) method Utilization in
current study*
Myelin basic protein (SMI94) Myelinated axons Sternberger monoclonals; 1/2000 ROI, WSA, LPA
NeuN Neuronal marker Chemicon; 1/2000 LPA
Neurofilament: non-phosphorylated
(SMI32)
Pyramidal cell bodies (layer III, V; normal
cortex), axons; in FCD type II, DN
Sternberger monoclonals; 1/500 ROI, LPA
Neurofilament: phosphorylated
(SMI31)
Axons; in FCD type II, DN Sternberger monoclonals
(USA); 1/5000
LPA
Synaptophysin Synaptic density Dako; 1/100 ROI, LPA
MAP2 Neuronal cell body and dendrites Sigma; 1/5000 ROI, WSA, LPA
Albumin Regions of blood–brain barrier breakdown Dako; 1/80 000 ROI
GFAP Reactive cellular and chronic fibrillary gliosis Dako; 1/2500 ROI, LPA
Nestin Acute gliosis/BC Chemicon; 1/8000 LPA
Calbindin Interneurons (cortical layers II–III mainly) Abcam; 1/40 LPA
CD68 Microglia Dako; 1/100 ROI, qualitative
CD34 Vasculature: tumor cells in LEAT, BC in FCD Leica/Novocastra; 1/50 Qualitative
*Indicates which markers were used in different studies.
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for T1 (P < 0.05) and T2* (P < 0.01) (Figure 1D) and between
normal cortex and FCD cortex for MTR (P < 0.05).
Quantitative pathology and MRI correlations
Myelin
In SMI94/MBP-stained sections there was a significant inverse
correlation between the LI and qMRI measures in the 43 ROI for
T1 (P < 0.005) (Figure 2A,C,D), T2 (P < 0.005; Spearman’s cor-
relation) (Figure 2B,E) and T2* (P < 0.05); there was a positive
correlation between SMI94/MBP and MTR (P < 0.05). When
considering normal white matter ROI alone, a significant inverse
correlation between SMI94/MBP and both T1 and T2 was still
observed (P < 0.05). With WSA, there was also a significant
inverse correlation between SMI94/MBP and T2 (P < 0.05).
Neuronal density
In MAP2-stained sections, there was a significant positive corre-
lation between the LI and qMRI measures over all 43 ROI for T1
(P < 0.005) (Figure 3A,D,E) and T2* (P < 0.05). When consider-
ing normal white matter ROI alone, there was also a positive
correlation between MAP2 LI and T1 (P < 0.05) (Figure 3B).
With WSA for pathology-negative cases, there was a positive
correlation between MAP2 LI and T2*, T2 (P < 0.05) (Figure 3F)
and an inverse correlation with MTR (P < 0.01). There were
no significant correlations noted for neurofilament LI and MRI
measures.
When the MAP2 and SMI94/MBP LI were expressed as a ratio,
over the 43 ROI there was a more significant positive correlation
with T1 (P < 0.0001), T2 (P < 0.001), T2* (P < 0.01) and negative
correlation with MTR (P < 0.01); with normal white matter ROI
alone there was a positive correlation between the MAP2/SMI94
ratio with both T1 and T2 values (P < 0.01) (Figure 3C).
Reactive pathological changes
There was a positive correlation between T2 measures in the
normal cortical ROIs and GFAP LI (P < 0.05). There was also a
positive correlation between albumin labeling in normal appearing
cortex and T1 measures (P < 0.05). Albumin was qualitatively
observed to stain the neuropil adjacent to vessels and some reac-
tive astrocytes, as previously described (31). Correlations were not
seen for GFAP or albumin in other ROI classes, and no significant
correlations were noted for microglial marker CD68.
Figure 1. Bar graphs of comparison of quantitative pathology values in
different regions of interest and quantitative magnetic resonance
imaging (MRI) values. (A) Pathology measures between normal cortex
and white matter and (B) normal white matter and white matter in the
region of focal cortical dysplasia (FCD). (C) MRI measures between
normal cortex and white matter and (D) normal white matter and
FCD white matter. Mann–Whitney test used for comparison between
groups and the significant values shown as *P < 0.05, **P < 001,
****P < 0.0001. MRI units for T1, T2 and T2* in seconds; magnetization
transfer ratio (MTR) is a ratio value.
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In three cases, localized ICE injuries were identified in the
sections submitted for 9.4T; the age of the injuries, taken as the
time from electrode insertion to tissue resection, were 3 days (case
6), 14 days (case 10) and 22 days (case 1). The high frequency of
ICE injuries in this cohort is accounted for by the high proportion
of cases that had undergone intracranial monitoring for “MRI-
negative” epilepsy. The injury site was clearly visible as a small
empty hypo-intense “cavity” in the cortex on MRI, and in the
marginal zones on T2, there was impression of increased signal
from 3- to 14-day-old injuries (Figure 4). Quantitative evaluation
of CD68 showed a trend for increased CD68 (P = 0.064 Mann–
Whitney) in these lesions compared with normal cortex, a decline
in MAP2 (P = 0.07, Mann–Whitney) but no significant alteration
in GFAP with days post-injury in this small group (Figure 4).
There was a significant reduction in T2* values in injured com-
pared with normal cortex (P = 0.02) (Figure 4).
Clinical correlations
There were no significant correlations betweenMRI and pathology
quantitative parameters in relation to age of epilepsy onset, dura-
tion of epilepsy or localization of the resection. There was also no
effect of fixation times on MR measurements; there was an inverse
correlation between fixation time and MAP2 and SMI32 staining
(P < 0.032 Spearman’s) but not for the other markers, including
SMI94/MBP.
LPA
Normal laminar cortex
LPA of normal cortex and white matter with neuronal- and layer-
specific markers are illustrated in case 8 (Figure 5); NeuN showed
a peak in layer II corresponding to the high packing density of
small neurons (Figure 5A,C) whereas neurofilament confirmed
increased labeling in lower compared with superficial cortical
layers (Figure 5B,C) with a small fluctuation in mid-cortical
layers, reflecting the region between the tramline-like bands of
labeling of the dendrites of the pyramidal neurons in layers III, V
and VI with their high neurofilament content. Synaptophysin by
contrast showed a flat labeling intensity profile through the cortex
reflecting the more homogenous staining with a relatively
sharp drop at the cortical–white matter boundary (Figure 5C). LPA
for SMI94/MBP showed increased intensity in deeper cortical
layers corresponding to the radial fibers with a small wave in
mid-layers (layer IV) likely reflecting horizontal myelinated fibers
Figure 2. Quantitative pathology and magnetic resonance imaging (MRI) correlations with SMI94/myelin basic protein (MBP) marker. Significant
inverse correlations were observed with (A) T1 and (B) T2 values overall MRI (C) case 9 (pathology negative) section stained with SMI94/MBP stain
and (D) T1 and (E) T2 sequences on 9.4T MRI. Bar = 5 mm.
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(Figure 5C). GFAP line profiles were highest in layer I and white
matter corresponding to the Chaslin’s gliosis and white matter
gliosis, respectively (Figure 5A,C). Calbindin showed lower inten-
sities overall, reflecting low density of labeled neurons, but higher
in outer cortical layers (I–III) compared with deeper cortex in
keeping with cell distribution (Figure 5C). LPA of normal cortex
in cases 4, 6, 9 and 11 (Figures S1–S4b) were broadly similar:
alterations in line profile intensity in myelin stains (MBP/SMI94)
in mid-layers correlating to horizontal myelinated fibers were more
apparent in some cases (case 9; Figure S2 and case 11; Figure S3)
than others (case 6; Figure S1). Similarly with neurofilament
stains, waves in the LPA intensity in mid-layers, correlating to the
zone between dendrites of pyramidal layers III and V, were promi-
nent in cases 6, 9 and 4 (Figures S1, S2 and S4b) but less pro-
nounced in others (case 11; Figure S3). These differences between
normal cases likely reflect normal regional, anatomical variations
in cyto- and myelo-architecture.
LPA in MRI sequences confirmed the qualitative impression of
increased signal intensity in outer cortical layers in T2 as previ-
ously described (12) (Figure 5D,G) and to a lesser extent in T1
(Figure 5F,H). In addition, waves in the LPA intensity were
observed in mid-cortex (Figure 5H) and likely correspond to the
profiles observed in neurofilament and myelin-stained sections in
layer IV region. The MTR showed a more uniform, flat line profile
through the cortex, changing at the white matter. LPA in further
cases of normal cortex (Figures S1–S4b) supported these findings,
with corresponding fluctuation in the profile intensity of T2 and
T2* sequences in mid-cortex.
Dyslaminar cortex in FCD
LPA of dysplastic cortexwith dyslamination is illustrated by case 4,
10 and 13 (Figure 6). In case 4, preoperative in vivo MRI was
normal, resected frontal lobe was macroscopically unremarkable
(Figure S4A) but FCD IIA confirmed histologically in the depth of
one sulcus,with numerous dysmorphic neurons scatteredwithin the
cortex but absent balloon cells (Figure S4A). LPA carried out on the
FCD region compared with adjacent normally laminated cortex
showed lower overall intensity values for NeuN (Figure S4A) and
altered line profile for MAP2 (Figure S4B,C) in FCD, correlating
Figure 3. Quantitative pathology and magnetic resonance imaging
(MRI) correlations with microtubule-associated protein 2 (MAP2). There
was a significant positive correlation with T1 in all 43 regions of interest
(ROI) (P < 0.005, Spearman’s correlation) (A). There was a significant
positive correlation with T1 in normal white matter regions of interest
(P < 0.05, Spearman’s correlation) (B). When ratios of microtubule-
associated protein 2 : SMI94/MBP were calculated for, there was a
significant positive correlation overall ROI for all MRI sequences (T1, T2,
T2* and MTR; P < 0.01 to P < 0.0001 see text) and as shown here for
normal white matter ROI alone with T2 (P < 0.01) (C). (D) MAP2 stained
section of case 2 (pathology negative; inset shows the single white
matter neurons and processes within the normal white matter. (E) Case
2 with T1- and (F) T2-weighted MRI sequences at 9.4T. Bar = 5 mm in
D (∼300 μm).
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with reduced neuronal labeling and reflecting abnormal neuronal
density and distribution, in keeping with previous stereological
quantitative studies in FCD type II (30). Similarly, LPA of T2 and
T2* (Figure S4A,B,C) also showed differences in intensities
between the normal and FCD regions, but there were no obvious
differences forT1 andMTR (Figure S4B,C).These observations on
LPA were also reflected in the qMRI values for this region of FCD
IIA that showed lower T2 and T2* values compared with both
the adjacent cortex as well as mean values for normal cortex in
the whole series. In case 13 with a perinatal infarct and FCD type
IIId (Figure 6A,B), with severe abnormalities of the cortical
myeloarchitecture and cyto-architecture (Figure 6E,G), LPA of
T2-weighted images (Figure 6C) showed distinct lamination corre-
sponding to the abnormal neuronal and myelin cortical layering.
LPA in a third case with dysplasia (FCD IIB) (case 10; Figure S5)
also showed abnormal line profiles, with flatter contours observed
on NeuN-, myelin- and neurofilament-stained sections as well
as T2*, T2 and T1, reflecting abnormal cortical lamination and
myelo-architecture.
DISCUSSION
Further technical advances in MRI, including increased field
strength, improvements in image resolution and post-processing
quantitative analysis, are likely to improve future detection of
subtle FCD and mild malformations in epilepsy (22). Such
advances, however, need to be validated with comparative neuro-
pathology, still regarded as the gold standard in the diagnosis and
Figure 4. Intracranial electrode (ICE) injuries.
In three cases ICE injury sites were
represented within the tissue blocks
scanned at 9.4T magnetic resonance
imaging. The ages of these ICE injuries (time
from electrode insertion to the time of
tissue resection) were 3, 14 and 22 days,
representing acute to subacute stages of
cellular organization. The position of the
injury is arrowed in T2 image with evidence
of intensity at the margin of the injury cavity
noted. The ICE injury site is shown on the
GFAP stain (with the cavity indicated by a
black arrow), indicating the reactive cellular
margin of astrocytes (shown in high
magnification in the corresponding column
on the right side). Graphical representation
of values for the region of interest
corresponding to the ICE injury is shown in
the bar chart with an increase in GFAP and
CD68 labeling index (LI), decline in
microtubule-associated protein 2 LI and T2*
alterations with age of the ICE injuries.
(T2 and T2* values are shown at ×101). Bar
equivalent to ∼1000 μm in middle column
GFAP and ∼50 μm in right hand column
GFAP).
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classification of lesion-based epilepsies (3, 22). In this study we
have aimed to address this need through correlating ex vivo 9.4T
qMRI measures with quantitative immunohistochemistry.We have
shown significant correlations between MRI measures and myelin
and neuronal density measures, even in histologically “normal”
appearing white matter. Such correlations show the potential of
high-resolution MRI in the detection of FCD and mild MCD with
subtle white matter pathological changes.
Cortical 9.4T MRI and neuropathology in epilepsy Reeves et al
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FCD
Established in vivo MRI hallmarks of FCD type II include thick-
ening of the cortex, a less distinct gray–white matter interface
and increased signal intensity in T2/FLAIR, with reduced or
hypointense T1 signals in the white matter (5, 22, 33). It is rec-
ognized that not all confirmed FCD II show these alterations and
there is evidence for improved MRI detection of FCD with the
application of quantitative methods (2, 33). The pathological cor-
relate of white matter T2 and FLAIR signal abnormalities is con-
sidered to reflect reduced myelin content (3, 6). Hypomyelination
of the white matter in the region of FCD II is a common, but not
essential, histological feature (23), confirmed through quantita-
tive immunohistochemistry in more subtle cases (23, 28). The
etiology of white matter hypomyelination is less well understood;
it may represent a developmental deficit in local oligodendroglial
maturation and myelination or reduced density of normally
myelinated axons in the region of FCD (23, 28). In this current
study in non-FCD epilepsy cases, we demonstrated an inverse
correlation between myelin immunolabeling and T2 over all ROI
(including cortex and white matter) as well as a significant cor-
relation when including only ROI from histologically unremark-
able appearing white matter. This demonstrates the potential
of 9.4T MRI to detect subtle differences in white matter
myelination that could be implemented in the localization of
occult FCD in patients with cryptogenic focal epilepsy as well as
in the detection of other white matter myelination abnormalities
recognized to occur in temporal lobe epilepsy (4, 11, 26). The
present series also included a 3T “MRI occult” FCD II case, in
which we confirmed a reduction in white matter myelin labeling
and significant increase in T1 and T2* with 9.4T MRI in the
dysplasia region with quantitative analysis compared with
normal values.
Mild MCD
Mild MCD encompass subtle (presumed developmental) cortical
and white matter abnormalities and remain one of the more con-
troversial entities described in focal epilepsies, both in view of
their preoperative detection, histological criteria, biology and sig-
nificance (3). Nevertheless they may represent a “biomarker” for
focal epilepsy. In this study we confirmed a significant correlation
between MAP2 neuronal labeling in the white matter and quanti-
tative T1 measures, supporting the ability of 9.4T MRI to detect
pathologically elevated white matter neuronal numbers. Mild
MCD type II is currently poorly defined as an “excess” of single
neurons in the white matter (3). In a recent quantitative analysis of
142 temporal lobe epilepsy cases utilizing WSS methods (19) we
confirmed higher white matter neuronal densities in epilepsy
patients (>2298 cells/mm3) compared with controls; however, the
clinical significance of this finding, in terms of epilepsy control
following surgery, remained unclear. In the current study we also
implemented WSS, which we have shown a more efficient and
reliable method for the quantitative analysis of larger ROI such as
the white matter (19). We observed a correlation between white
matter MAP2 neuronal labeling, T2*, T2 and MTR. This supports
continued implementation and development of WSS technology
for the rapid analysis of epilepsy lobectomy specimens. Indeed,
limitations of the size of white matter ROI, which were necessary
in our previous studies of in vivo 3T MRI/pathology correlations
implementing stereology, may be one explanation for the lack of
correlation between white matter neuronal number and qMRI then
observed (9). Furthermore, in this current study we included
MAP2 for the assessment of neuronal density as an alternative to
previously employed NeuN marker. Threshold-based analysis of
the area of MAP2 immunostaining, which labels both neuronal
cell body and dendrites, as an alternative to more traditional
neuronal density measurements based on nuclear NeuN labeling
(9, 19), may prove a more sensitive marker in the evaluation of
altered white matter neuronal populations. Furthermore, Mild
MCD II-like pathologies are also recognized in other neurological
conditions as schizophrenia, autism spectrum disorders (24, 35) as
well as epilepsy and although its relevance, in terms of a prognos-
tic marker, remains uncertain its in vivo detection may be impor-
tant as a biomarker of abnormal neurodevelopment in these
conditions.
Figure 5. Line profile analysis (LPA) in normal cortex (case 8). (A)
Merged and superimposed images, recolored for illustrative purposes, of
NeuN (blue), myelin (green) and GFAP (red); same area is shown in (B)
labeled with neurofilament/SMI32 in gray scale. Gray scale monochrome
images were used for LPA along vectors drawn at an axis perpendicular
to the pial surface through all cortical layers (indicated with the red lines
SMI32/neurofilament stain in B). (C) Graphical representation of LPA of
mean intensities of labeling between the two vectors in this case; the
x-axis represents the distance through the cortex scaled as 0 = the pial
boundary to 100 = cortical white matter boundary (shown in red on panel
B and the approximate position of cortical layers, as measured with
image pro plus on NeuN-stained sections, is shown at the bottom of
graph in C in red text). Intensity of gray-scale signal is shown in the y-axis
(note: the graphs have been inverted for illustration so higher y-value
corresponds to lower gray scale/greater immuno-positive reaction).
Synaptophysin shows a relatively flat intensity line profile through the
cortex until the white matter junction; neurofilament (SMI32) shows
greater immunostaining intensity in deeper compared with superficial
cortex with irregularities in the line profile in the mid-layers (double
arrows in B and C) reflecting the zones between the pyramidal cell
dendrites in layers III and IV and V. The profile forMBP/SMI94 also shows
increased intensity of immunostaining on LPA in deeper cortical layers
corresponding to the radial fibers, with an impression of a small peak in
mid-layers (arrow in A and C), which is likely detecting the horizontal
myelinated fibers. NeuN LPA is low in cell-free layer I and shows peak
intensity in LPA in layer II, corresponding to the greater neuronal packing
density of small neurons, whereas the neurons in deeper cortical layers
are more widely spaced and the line profile flattens off until the white
matter. GFAP LPA intensities peaked in layer I (corresponding to the
Chaslin’s gliosis) and in the white matter. Calbindin showed lower overall
intensities, due to the overall low density of immunopositive cells, but
with highest intensities in outer cortical layers (I–III). MRI sequences are
T2 [D; bar indicates region of LPA and shown in higher magnification in
(G)], MTR (E) and T1 (F). (H) LPA of MR sequences in T2 and T2* and to
some extent T1 show higher intensities of LPA in superficial cortical
layers with a small peak in mid-layers on T2 (arrow) approximately
corresponding to the region of altered intensity in the neurofilament and
myelin sections in the region of layer IV.
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Previous qMRI studies
Our findings are in keeping with published ex vivo studies corre-
lating qMRI and quantitative neuropathology measurements in
other neurological conditions. Schmierer et al (27), in a study of
PM tissues from patients with multiple sclerosis using 9.4T MRI,
showed an inverse correlation between MBP and T2 in the cortex
and an inverse correlation between MBP and T1 in the white
matter. Spencer et al (29), in a mouse model ofAD, showed that T1
correlated better with myelin density than cell density in the
cortex. In a study of PM AD brains, Gouw et al also noted that
increased white matter myelin loss was associated with increased
T2 signal (14). In previous studies of 7T MRI of temporal lobe
epilepsy samples, areas of in-homogenous signal intensity in the
white matter on T2 corresponded to fewer myelinated and
unmyelinated axons on ultrastructural analysis (11). It is also plau-
sible that the observed white matter microstructural alterations of
reduced and abnormal white matter myelination (11, 23, 28) and
increased neuronal density operate synergistically to influence
MRI signal alterations. Indeed, in the current study, when we
expressed MAP2 and myelin as a ratio, there was an augmented
statistical association with qMRI measures.
LPA and dyslamination
We utilized LPA to compare intensity gradients in normal laminar
cortex and regions with histologically proven FCD types.
Dyslamination (abnormal neuronal layering) is a hallmark of FCD
type II and the only pathological abnormality in FCD type I (3). It
can be evident on cresyl violet (Nissl) stained sections, although can
be subtle with improved detection shown through application of
cortical layer-specificmarkers (15, 25), some ofwhichwere applied
in the current study. Although less recognized, the cortical myelo-
architecture is also frequently altered in FCD, supported by
previous quantitative studies (28) and ismore dramatic in FCD type
IIId as exemplified by the case in this series. Clarification of
dyslamination in in vivo MRI could facilitate detection of subtle
FCDandbe utilized as a potential diagnostic technique for currently
“occult” patients with electro-clinically focal seizures. Previous
MRI studies of human brain tissue samples have employed similar
LPA methods. Fatterpekar et al. (10) imaged PM samples of the
calcarine cortex at 9.4T and correlated thiswithNissl andLuxol fast
blue stains for myelin; they visualized bands of low signal in
mid-layers on MRI images corresponding to the myelinated fibers
in the external band of Baillarger. Walters et al also confirmed the
ability of high-resolution MRI to detect cortical lamination in PM
samples in regions outside the calcarine cortex (34) and noted that
this correlated overall better with cortical myelo-architecture than
cyto-architecture, as also in a study by Eickhoff et al (7). We were
also able to visualize cortical lamination with MRI in a PM speci-
men taken from the temporal cortex, where the intracortical hori-
zontal myelin plexus is less pronounced than in the visual striate
cortex. Using similar LPAmethod, Garbelli et al (12) carried out an
ex vivo 7TMRI of surgical epilepsy resections of FCD type III type
a (temporal cortical dysplasia adjacent to hippocampal sclerosis).
In normal cortex, they noted intensity differences onT2 between the
upper and lower cortex separated by a dip of lower intensity signal
correlating with cortical myelination patterns and the neuronal
density of layer IV on NeuN sections; in FCD IIIa cases, however,
this dip in mid-layer intensity was lost and the T2 line profile
through the cortex was flatter without a clear difference between
supragranular and infragranular cortex (12). They concluded that
altered LPA in dysplasia is strongly correlated with abnormal
cortical myelination patterns.
With LPA we confirmed similar intensity profiles for T1 and T2
in normal cortex from varied cortical locations, with NeuN,
neurofilament and MBP markers more consistently revealing con-
tours and linear gradients across cortical layers and correlating
with MRI line profiles. Furthermore, we observed differences in
LPA on 9.4T MRI in histologically confirmed FCD II and FCD
IIId reflecting the abnormal lamination, altered neuronal popula-
tions and abnormal myelo-architecture. These studies support the
potential application of LPA techniques in the identification and
discrimination of FCD types.
Reactive and secondary cortical changes
Gliosis is a ubiquitous finding in surgical resections from patients
with epilepsy but of unknown cause. Furthermore, inflammatory
changes and blood–brain barrier breakdown are reported that
could influence MRI appearances (1). In our quantitative analysis
of normal cortex, we noted a positive correlation between T2 and
gliosis (GFAP) and albumin leakage and T1, suggesting that 9.4T
MRI signals may be influenced by subtle reactive cellular changes.
There is a great incentive to understand processes of gliosis and
brain repair responses, both the pathological mechanisms and MRI
correlates, in particular the time course of early cellular changes,
reparative neuro-glial interactions as well as identifying any mala-
daptive, detrimental effects. We have previously used ICE “inju-
ries” in patients with epilepsy as a model to study the time course
of cellular responses and gliogenesis (13). In the current series we
had three injuries of varying ages (acute to subacute) and although
a small number, quantitative histological analysis confirmed the
expected microglial responses accompanied by progressive loss of
Figure 6. Line profile analysis (LPA) in case 13 with focal cortical
dysplasia-type iiid. (A) In vivo magnetic resonance imaging (MRI)
showing right occipital “ulegyric” malformation and (B) post-fixed
resected surgical specimen prior to 9.4T MRI. (C) 9.4T MRI T2 image
illustrating one malformed gyrus and corresponding gyrus shown on
sections stained with (E) NeuN (G) and myelin basic protein/SMI94 (G);
black arrow in each indicates the region for LPA (shown at higher
magnification in insets in E and G). The outermost layers are hyperin-
tense on T2 and two peaks of hyperintensity (shown as arrowheads onC,
D) correspond to a superficial and deep neuronal layer (shown with arrow
heads on E in inset, and on F as dips in LPA intensity corresponding to the
greater immunolabeling). A deeper hypointense band (marked with
chevron on C and D) corresponds to increased myelinated fibers in the
deep cortex/subcortical region (shown with chevrons on G and on H as a
fall in intensity due to increased labeling). In the graphical representation
of LPA of mean intensities (D, F andH), the x-axis represents the distance
through the cortex, scaled as 0 = the pial boundary to 100 = cortical
white matter boundary. E and G are shown at ×4 magnification.
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neurons and dendrites as highlighted with a reduction in MAP2
and a marginal astroglial reaction. Despite the gliotic margin and
the qualitative impression of a rim of increased signal intensity
around the injury cavity we noted a significant fall in T2* with
days post-injury compared with normal cortex. Although we have
only three samples, it is likely that the T2* measure in these cases
reflects the overall loss of neurons rather than the cellular glial
reaction. Nevertheless, these cases highlight the potential of 9.4T
MRI in the evaluation of this “model” of cortical injury; by includ-
ing more ROI, representing zones of injury from the necrotic
center to the penumbra as well as greater number and age of
injuries, the sequence of cellular alterations in brain repair and
imaging alterations could be teased out.
In conclusion, this study demonstrates the feasibility of quanti-
tative 9.4T MRI to detect subtle differences in cortical and white
matter neuronal numbers and myelination in histologically normal
appearing cortex and white matter and LPA as a useful tool in the
detection of subtle cortical dyslamination. These methods have the
potential to be translated to the in vivo detection of mild MCD and
occult FCD cases in epilepsy.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online
version of this article at the publisher’s web-site:
Figure S1. Line profile analysis (LPA) for case 6 (no cortical
dyslamination).
Figure S2. Line profile analysis (LPA) for case 9 (no cortical
dyslamination).
Figure S3. Line profile analysis (LPA) for case 11 (post-mortem
sample with no dyslamination).
Figure S4. (A) Line profile analysis (LPA) in FCD IIA (case 4).
Figure S5. Line profile analysis (LPA) for case 10 in FCD IIB.
Reeves et al Cortical 9.4T MRI and neuropathology in epilepsy
15Brain Pathology •• (2015) ••–••
© 2015 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology
